Evaluation Methods and Design for Bioartificial Liver Based on Perfusion Model
A bioartificial liver (BAL) is a medical device entrapping living hepatocytes or immortalized cells derived from hepatocytes. Many efforts have already been made to maintain the functions of the hepatocytes in a BAL device over a long term. However, there is still some uncertainty as to their efficacy. and their limitations are unclear. Therefore, it is important to quantitatively evaluate the metabolic functions of a BAL. In previous studies on in vitro BAL devices, two test methods, an initial bolus loading and constant-rate infusion plus initial bolus loading, were theoretically carried out to obtain physiologic data on drugs. However, in the current study, the same two methods were used as a perfusion model and derived the same clearance characterized by an interrelationship between the perfusate flow rate and intrinsic clearance. The interrelationship indicated that the CL increased with an increasing perfusate flow rate and approached its maximum value, i.e. intrinsic clearance. In addition, to set up an in vivo BAL system, the toxic plateau levels in the BAL system were calculated for both series and parallel circuit models. The series model had a lower plateau level than the parellel model. The difference in the toxic plateau levels between the parallel and series models increased with an increasing number of BAL cartridges.
- de Bartolo, L., S. G. Jarosch-Von, A. Haverich, and A. Bader (2000) A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: Cell viability and tissuespecific functions. Biotechnol. Prog. 16: 102-108
- Tilles, A. W., H. Baskaran, P. Roy, M. L. Yarmush, and M. Toner (2001) Effect of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol. Bioeng. 73: 379- 389
- Patankar, D. and T. Oolman (1991) Wall-growth hollow fiber reactor for tissue culture: I. Preliminary experiments. Biotechnol. Bioeng. 37: 80-92
- Rowland, M. and T. N. Tozer (1989) Clinical Pharmacokinetics: Concepts an Applications. Lea & Febiger, Philadelphia, USA
- Lanza, R. P., D. H. Butler, K. M. Borland, J. E. Staruk, D. L. Faustman, B. A. Solomen, T. E. Muller, R. G. Rupp, T. Maki, A. P. Monaco, and W. L. Chick (1991) Xeno transplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. USA 88: 11100-11104
- Gion, T., M. Shimada, K. Shirabe, K. Nakazawa, H. Ijima, T. Matsushita, and K. Funatsu (1999) Evaluation of a hybrid artificial liver using a polyurethane foam packed-bed culture system in dogs. J. Surg. Res. 82: 131-136
- Hughes, R. D. and R. Williams (1996) Use of bioartificial and artificial liver support devices. Sem. Liver Dis. 16: 435-444
- Nyberg, S. L., W. D. Payne, B. Amiot, K. Shirabe, R. P. Remmel, W. S. Hu, and F. B. Cerra (1993) Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model. Transplant. Proc. 25: 1944-1945
- Park, Y. G., H. Iwata, S. Satoh, T. Uesugi, and H.？W. Ryu (2003) Method for evaluating metabolic functions of drugs in bioartificial liver. Biotechnol. Bioprocess Eng. 8: 41-46
- Sakai, Y., K. Naruse, I. Nagashima, T. Muto, and M. Suzuki (1999) A new bioartificial liver using porcine hepatocytes spheroids in high-cell-density suspension perfusion culture: In vivo performance in synthesized culture medium and in 100% human plasma. Cell Transplant. 8: 531- 541
- Sardonini, C. A. and D. DiBiasio (1992) An investigation of the diffusion-limited growth of animal cells around single hollow fibers. Biotechnol. Bioeng. 40: 1233-1242
- Demetriou, A. A., J. Rozga, L. Podesta, E. Lepage, E. Morsiani, A. D. Moscioni, A. Hoffman, M. McGrath, L. Kong, H. Rosen, F. Villamil, G. Woolf, J. Vierling, and L. Makowka (1995) Early clinical experience with a hybrid bioartificial liver. Scand. J. Gastroenterol. 30: 111-117
- Yarmush, M. L., J. C. Dunn, and R. G. Tompkins (1992) Assessment of artificial liver support technology. Cell Transplant. 1: 323-341
- Park, Y. G., Y. S. Son, and H.-W. Ryu (2003) Perfusion model for detoxification of drugs in a bioartificial liver. Int. J. Artif. Organs 26: 224-231
- Kamlot, A., J. Rozga, F. D. Watanabe, and A. A. Demetriou (1996) Review: Artificial liver support system. Biotechnol. Bioeng. 50: 382-391
- Rozga, J., E. Morsiani, H. Fujioka, and A. A. Demetriou (1993) Anhepatic pig-evaluation of a model. J. Hepatol. 18: S72-S79
- Asonuma, K., J. C. Gibert, J. E. Stein, T. Takeda, and J. P. Vacanti (1992) Quantitation of transplanted hepatic mass necessary to cure the gunn rate model of hyperbilirubinemia. J. Pediat. Surg. 27: 298-301
- Sussman, N. L., G. T. Gislason, C. A. Conlin, and J. H. Kelly (1994) The hepatix extracorporeal liver assist device: Initial clinical experience. Artif. Organs. 18: 390-396
- NDSL :
유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.
원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.
NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.
- 이 논문과 함께 출판된 논문 + 더보기